When the weather suddenly turns cold,，& ldquo; San Gao & rdquo; The disease is easy to show a high incidence。"China Health and Family Planning Statistics Yearbook" shows，2003，Cycling system diseases are explosive growth，Especially in the five years of 2008 to 2013，The prevalence of two weeks is doubled，Cardiovascular and cerebrovascular diseases become the first killer that endangers the health of the people (see Figure 1)。Mine.com retail monitoring database display，In the first half of 2016，Beijing、Guangzhou、Jinan、Four cities in Nanjing (hereinafter referred to as 4 cities) & ldquo; San Gao & rdquo; the market for medication increased by 1.9%year -on -year，Where，The most concentrated market concentration in the market for lowering blood lipids，Second, the market for hypoglycemic medication，The market concentration of the antihypertensive drug market is low。

 

 

  Market Overview

 

  The highest concentration of blood lipids is the highest

 

  From the total & ldquo; San Gao & RDQUO; the retail data of the disease in the 4 cities in the first half of 2016，The most concentrated market concentration in the market for lowering blood lipids，Second, the market for hypoglycemic medication，The market concentration of the antihypertensive drug market is low (see Table 1)。

 

 

  My stake betting appComments: Chronic diseases due to long medication cycle，The characteristics of the audience group and other characteristics，Become a must -have place for many pharmaceutical companies and retail pharmacies。But in the retail market，lower blood pressure、The degree of competition for blood glucose and blood lipids is different。Where，There are more varieties of antihypertensive varieties，Competition is the most intense。From the RSOM index of the leader brand，Leading brands that only reduce blood lipids have more advantages，The market intervention is large，and the market for hypoglycemic and antihypertensive drugs is relatively scattered。

 

  Slightly expanded

 

  Midnet retail monitoring statistics data show，In the first half of 2016，& ldquo; San Gao & RDQUO; The market for the medication of the disease is 1.9%year -on -year，The year -on -year increase in the number of sub -category markets (see Figure 2)。

 

 

  Comments: In recent years，With the advancement of community medical reform，zero -difference price in the base medicine、Directory expansion of the base medicine、Under the influence of the improvement of reimbursement ratio，The passenger flow of retail pharmacies is gradually diversion。Another，& ldquo; San Gao & rdquo; Drug medication is mostly prescription medicine，You need to use the doctor's prescription to buy at a pharmacy，Prescription outflow is still one of the difficulties that retail pharmacies need to be broken，Make & ldquo; San Gao & rdquo; Disease medication is slow in the retail market。

 

  Liphamium reduction

 

  Jetta class dominates one party

 

  Drug reduction of blood lipids refers to a drug that can reduce the triglyceride of plasma glycerol or reduce plasma cholesterol，Mainly divided into statins、Bette、Tobacco acid and gall acid chelating agent, etc.。In the first half of 2016，4 Cities Total Bitten Drugs are far ahead with 83.3%of the market share，increased by 2%year -on -year (see Figure 3)。

 

 

  Comment: Hisatin drugs are divided into natural compounds (such as Schipsia and Luoceline) and fully artificial synthetic compounds (such as Atorvastatin and Flobatin)。Current，stake betting appThe retail market uses Atropanda to running Jetin -like hyperlipidemia market，The share is as high as 64.7%，In the first half of 2016, the total 4 cities in the first half of 2016 increased by 1.9%year -on -year (see Figure 4)，Keep eating other categories markets。

 

 

  antihypertensive category

 

  Calcium channel blocking agent leaders

 

  In the first half of 2016，4 Cities in cities in the retail market for antihypertensive drugs，Chemical drugs account for 96.8%of the market share，1.2 percentage points increased by 1.2 percentage points from the same period last year，Among them, calcium channel blockers (CCB) lead the booster chemical market，Followed by vascular tension II receptor antagonist (ARB)。& beta;、Vascular tensionin conversion enzyme inhibitors (ACEI)、Diuretic's market share is relatively low (see Figure 5)。

 

 

  Comments: In recent years，Chinese medicine、Healthcare products have received widespread attention。Many patients with hypertension are taken after taking Chinese medicine，Blood pressure was controlled in the short term，but still failed to achieve the effect of steady blood pressure。News exposure to illegally add chemical drugs with antihypertensive health products，Patients gradually learned in the process of taking the medicine and the importance of the control of high blood pressure dosage and the importance of continuous medication，The compliance of chemicals gradually increases。

 

  Note: CR4 = The top 4 share of the industry; CR8 = the top 8 industry share concentration。

 

  Plagluscence

 

  Three points in the world, good growth

 

  The hypoglycemic medication in my country's retail market is mainly oral drugs，In the first half of 2016，4 Cities for cities for hypoglycemic drug markets are mainly sulfa，Double 胍，A-glucosidase inhibitor three-pointers in the world (see Figure 6)。Sulfur urine hypoglycemic medication ranks first in 30.0%，and the second -line dual -cricket ranking of the first -line anti -voltage medication of the drug guide ranked second。Double category is best to grow in various types of hypoglycemic medication，increased by 1.2%year -on -year。A-glucosidase inhibitor ranks third in the third place with a market share of 21.2%，Its characteristics are: there are not many varieties，stake betting appBut the market is very concentrated，belongs to the extremely high oligopoly market，The market resources of this type of hypoglycemic drugs are mainly concentrated in the first、On the second brand。

 

 

  Comments: According to the latest statistics of the Global Diabetes Map released by the International Diabetes (IDF) in 2015，Every 11 adult species in the world have 1 person with diabetes (totaling 415 million)，Among them, about half of them have not been diagnosed。China with a large population base，This is undoubtedly a large medical expenses expenditure。

 

  The finishing touch

 

  Creation of slow disease management closed -loop value chain

 

  /Bai Ting (Shenzhen) Health Management Co., Ltd.

 

  佟 胜/

 

  The data of this article shows，& ldquo; San Gao & rdquo; The disease is easy to show a high incidence，But，& ldquo; San Gao & RDQUO; The drug market increased by only 1.9%year -on -year，Obviously lower than the growth rate of the incidence of disease。And，The data from the text can also be confirmed，Current，Self -management and medication of patients with chronic diseases in my country is not high，The main manifestations are & ldquo; Four low & rdquo;: low knowledge and harm of disease and harm，Active monitoring of the awareness and implementation rate of the disease is low，遵 遵、Low standard for medication，Self -management and control rate low。

 

  So，Social pharmacies have great potential and development opportunities in the aspect of changing patients with chronic diseases & ldquo; Four low & rdquo;。Social pharmacies carry out professional service projects，Cultivate Excellent Service Specialist、Project Supervisor、Training Supervisor，Plan the company's chronic disease product package in accordance with customer needs，Establish a professional service center of Cold Diseases，Extended Special Medical Service，Create a doctor、Medicine、Understand service closed -loop value chain，is the king of sustainable development in the future。

 

  Slow disease management brings the drugstore opportunity

 

  /Retail Center researcher Wu Xiaoqiong/

 

  2015，The three departments including the Human Resources and Social Security Department of Zhejiang Province issued stake online sports bettingthe "Notice on Carrying out Pilot Pilot on Continuous Prescriptions for Chronic Diseases"，Start the pilot chronic disease continuous prescription。This policy is conducive to the treatment market for chronic diseases to gradually transfer to primary medical institutions (zero differences) and pharmacies (convenience)。

 

  Retail pharmacies must undertake outflow prescriptions，You must strengthen professional service。At present, there are many chain companies testing the water testing project，Establish a pharmacy based on chronic diseases，This requires not only the establishment of a chronic disease file，It also needs to improve the corresponding medication tracking and safe medication guidance。Once the pilot is released，It will promote the development of chronic management of retail pharmacies。